0

Journal Articles

in Psychopharmacology
 41-60 of 97 Articles
JAMA Pediatrics | 
Advice for Patients |  September 01, 2012 FREE
Adolescent Opioid Abuse
Megan A. Moreno, MD, MSEd, MPH; Fred Furtner; Frederick P. Rivara, MD, MPH
Arch Pediatr Adolesc Med. 2012;166(9):880. doi:10.1001/archpediatrics.2012.1765.
JAMA Psychiatry | 
Original Article |  September 01, 2012
Association Between Common Variants Near the Melanocortin 4 Receptor Gene and Severe Antipsychotic Drug–Induced Weight Gain
Anil K. Malhotra, MD; Christoph U. Correll, MD; Nabilah I. Chowdhury, BSc; et al.
Arch Gen Psychiatry. 2012;69(9):904-912. doi:10.1001/archgenpsychiatry.2012.191.
INCLUDES: , Supplemental Content
JAMA Pediatrics | 
Editorial |  September 01, 2012
Adolescent Abuse of Pharmaceutical Opioids Raises Questions About Prescribing and Prevention
Caleb J. Banta-Green, PhD, MPH, MSW
Arch Pediatr Adolesc Med. 2012;166(9):865-866. doi:10.1001/archpediatrics.2012.590.
JAMA Pediatrics | 
Article |  September 01, 2012
Medical and Nonmedical Use of Prescription Opioids Among High School Seniors in the United States
Sean Esteban McCabe, PhD; Brady T. West, PhD; Christian J. Teter, PharmD; et al.
Arch Pediatr Adolesc Med. 2012;166(9):797-802. doi:10.1001/archpediatrics.2012.85.
JAMA Internal Medicine | 
Research Letters |  August 13, 2012
Prescription Drug Abuse and DEA-Sanctioned Drug Take-Back Events: Characteristics and Outcomes in Rural Appalachia
Jeffrey A. Gray, PharmD; Nicholas E. Hagemeier, PharmD, PhD
Arch Intern Med. 2012;172(15):1186-1187. doi:10.1001/archinternmed.2012.2374.
JAMA Internal Medicine | 
Perspectives |  August 13, 2012 FREE
Pain as a Cause of Agitated Delirium
Diane E. Meier, MD
Arch Intern Med. 2012;172(15):1130. doi:10.1001/archinternmed.2012.2088.
JAMA Internal Medicine | 
Invited Commentary |  August 13, 2012
When It's the Right Care, More Is Better:  Comment on “Palliative Care and Quality of Life” and “Pain as a Cause of Agitated Delirium”
Steven Z. Pantilat, MD, FAAHPM, SFHM
Arch Intern Med. 2012;172(15):1172-1173. doi:10.1001/archinternmed.2012.2894.
JAMA Internal Medicine | 
Editor's Correspondence |  August 13, 2012
Do Angiotensin Receptor Blockers Really Hold Promise for the Improvement of Cognitive Functioning?
Chittaranjan Andrade, MD; Praveen Fernandes, MD
Arch Intern Med. 2012;172(15):1191-1192. doi:10.1001/archinternmed.2012.2091.
JAMA Internal Medicine | 
Editor's Correspondence |  August 13, 2012
Do Angiotensin Receptor Blockers Really Hold Promise for the Improvement of Cognitive Functioning?—Reply
Ihab Hajjar, MD, MS; Wendy Mack, PhD, MS; Lewis Lipsitz, MD
Arch Intern Med. 2012;172(15):1191-1192. doi:10.1001/archinternmed.2012.3885.
JAMA Psychiatry | 
Original Article |  August 01, 2012
Prenatal Antipsychotic Exposure and Neuromotor Performance During Infancy
Katrina C. Johnson, PhD; Jamie L. LaPrairie, PhD; Patricia A. Brennan, PhD; et al.
Arch Gen Psychiatry. 2012;69(8):787-794. doi:10.1001/archgenpsychiatry.2012.160.
JAMA | 
Medical News and Perspectives |  July 11, 2012
CMS Seeks to Reduce Antipsychotic Use in Nursing Home Residents With Dementia
Mike Mitka
JAMA. 2012;308(2):119-121. doi:10.1001/jama.2012.7422.
JAMA Facial Plastic Surgery | 
Original Article |  July 01, 2012
Antidepressants and Bleeding Risk After Face-lift Surgery
Sanaz Harirchian, MD; Richard A. Zoumalan, MD; David B. Rosenberg, MD
Arch Facial Plast Surg. 2012;14(4):248-252. doi:10.1001/archfacial.2012.2.
JAMA Psychiatry | 
Original Article |  July 01, 2012
Effects of Medicare Part D Coverage Gap on Medication and Medical Treatment Among Elderly Beneficiaries With Depression
Yuting Zhang, PhD; Seo Hyon Baik, PhD; Lei Zhou, MS; et al.
Arch Gen Psychiatry. 2012;69(7):672-679. doi:10.1001/archgenpsychiatry.2011.1402.
INCLUDES: , Supplemental Content
JAMA Psychiatry | 
Original Article |  July 01, 2012
Antipsychotics During Pregnancy:  Relation to Fetal and Maternal Metabolic Effects
Robert Bodén, MD, PhD; Maria Lundgren, MD, PhD; Lena Brandt, BSc; et al.
Arch Gen Psychiatry. 2012;69(7):715-721. doi:10.1001/archgenpsychiatry.2011.1870.
JAMA Psychiatry | 
Original Article |  July 01, 2012
Maternal Use of Selective Serotonin Reuptake Inhibitors, Fetal Growth, and Risk of Adverse Birth Outcomes
Hanan El Marroun, PhD; Vincent W. V. Jaddoe, MD, PhD; James J. Hudziak, MD; et al.
Arch Gen Psychiatry. 2012;69(7):706-714. doi:10.1001/archgenpsychiatry.2011.2333.
JAMA Psychiatry | 
Original Article |  December 01, 2011 FREE
Reinforcement Learning and Gilles de la Tourette Syndrome:  Dissociation of Clinical Phenotypes and Pharmacological Treatments
Yulia Worbe, MD, PhD; Stefano Palminteri, MSc; Andreas Hartmann, MD; et al.
Arch Gen Psychiatry. 2011;68(12):1257-1266. doi:10.1001/archgenpsychiatry.2011.137.
INCLUDES: , Supplemental Content
JAMA | 
Original Contribution |  September 21, 2011 FREE
Cognitive Behavior Therapy Augmentation of Pharmacotherapy in Pediatric Obsessive-Compulsive Disorder:  The Pediatric OCD Treatment Study II (POTS II) Randomized Controlled Trial
Martin E. Franklin, PhD; Jeffrey Sapyta, PhD; Jennifer B. Freeman, PhD; et al.
JAMA. 2011;306(11):1224-1232. doi:10.1001/jama.2011.1344.
INCLUDES: , Supplemental Content
JAMA Psychiatry | 
Original Article |  January 03, 2011 FREE
Maintenance Treatment of Depression in Old Age:  A Randomized, Double-blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Combined With Antidepressant Pharmacotherapy
Charles F. Reynolds, MD; Meryl A. Butters, PhD; Oscar Lopez, MD; et al.
Arch Gen Psychiatry. 2011;68(1):51-60. doi:10.1001/archgenpsychiatry.2010.184.
JAMA Psychiatry | 
Original Article |  December 06, 2010 FREE
Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression
Zindel V. Segal, PhD; Peter Bieling, PhD; Trevor Young, MD; et al.
Arch Gen Psychiatry. 2010;67(12):1256-1264. doi:10.1001/archgenpsychiatry.2010.168.
JAMA | 
Review |  January 06, 2010 FREE
Antidepressant Drug Effects and Depression Severity:  A Patient-Level Meta-analysis
Jay C. Fournier, MA; Robert J. DeRubeis, PhD; Steven D. Hollon, PhD; et al.
JAMA. 2010;303(1):47-53. doi:10.1001/jama.2009.1943.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Psychiatry
Original Article  |  June 12, 2013
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
Callie L. McGrath, BA; Mary E. Kelley, PhD; Paul E. Holtzheimer, MD; et al.
JAMA Neurology
Observation  |  June 10, 2013
Serotonin Syndrome Associated With Clozapine Withdrawal
Elizabeth Stevenson, MD, MS; Frank Schembri, MD; Deborah M. Green, MD; et al.
JAMA
Viewpoint  |  May 9, 2013
Opioid Analgesics—Risky Drugs, Not Risky Patients
Deborah Dowell, MD, MPH; Hillary V. Kunins, MD, MPH, MS; Thomas A. Farley, MD, MPH
JAMA Surgery
Resident's Forum  |  May 29, 2013
Preoperative Superselective Mesenteric Angiography and Methylene Blue Injection for Localization of Obscure Gastrointestinal Bleeding
Madhava Pai, MS, FRCS; Adam E. Frampton, MSc, MRCS; Jagdeep S. Virk, MRCS; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems